We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Housebooker offers holiday accommodation in real peoples homes. They provide its clients with a way of generating a significant income through their managed services and aim to achieve a better return for their clients over what they would traditionally get from a buy-to-let. 
days to go: Expired investment: £12,950
My Friends Room allows travellers to rent accommodation from friends and friends of friends. Many vacation rentals can seem unsafe and impersonal. However renting from a friend or someone that has been recommended from a friend prevents this feeling of unsafety.
days to go: Expired investment: £97,870
The LetPal solution for private landlords is a full suite of competitively priced on-line services, from which landlords can select and pay for only those they require.
days to go: Expired investment: £70,000
Rightangled are a CQC registered healthcare provider specialising in genetic testing and is backed by the NHS England. They have designed and filed a patent for their Cardiac genetic test and are now seeking to expand their testing and telemedicine service into new markets and new tests.
days to go: Expired investment: £433,290
BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.
days to go: Expired investment: £451,506
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £270,543
Aerobit is a smart inhaler, a tool for tracking medication use that records each time inhalers are taken and comes in a variety of cool toy designs. Built in sensors can even tell if the inhaler has been shaken correctly. 
days to go: Expired investment: £116,960
Reducing the cost of orthopaedic equipment by using compression screws and titanium maxiangle locking plates. DC Surgical Supplies have acquired an exclusive license with Palmer & Baker with the aim of helping the NHS cut the cost of purchasing regular-use equipment by as much as 35%. Their product is CE Certified and has been featured in The Telegraph.
days to go: Expired investment: £99,000
Tourniglo is a company that has come up with a unique two in one emergency tourniquet with a built-in torch. The innovation was driven by an identified need within the emergency services to provide an immediately available light source in dim-lighted areas when undertaking a patient or casualty eye examination as well as for military and close protection staff who might need to inject intravenous medication in rural areas. The global tourniquet systems market is expected to reach half a billion US dollars by 2025. The company aims to launch the production of its first product. Additionally, Tourniglo has been featured on the BBC website and has won various medals at international events, including a 'Gold Medal' at the World Invention Awards. The company requires investment to set-up manufacturing, packaging and distribution, and grow sales for the first year of commercialisation.
days to go: Expired investment: £21,414
Exchange Train (ET) is an online comparison website where property solicitors have 24 hours to bid for the home-movers custom in real-time. ET argues that there are over 19,000 property solicitors in the UK each providing a different quality of service, price, and turnaround time. ET aims to overhaul this process. Its portal locates the top solicitors for the customer’s specific transaction, based not only on price but what's most important to the customer. ET has had over 10,000 visitors, generated over 650 quotes, and signed up 22 solicitors on its portal, to date. The company has also featured in TodaysConveyancer, The Property Industry Eye, and The Negotiator Magazine. It will use 30% of the investment towards accelerating website development, 36% towards boosting Public Relations (PR), 18% towards enhancing Google Ads and social media, and 16% towards growing business operations.

Pitch Rated

41%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £123,900
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph